This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Oncodesign Precision Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Maxime Laugeois - Innovator in Precision Medicine
Introduction
Maxime Laugeois is an inventor based in Paris, France. He is currently associated with Oncodesign Precision Medicine, where he contributes to advancements in the field of medical research. Although he has not yet been granted any patents, his work is focused on developing innovative solutions for healthcare.
Latest Patent Applications
Maxime Laugeois has submitted several patent applications, including:
- MACROCYCLIC LRRK2 KINASE INHIBITORS - Compounds of formula (I) are useful as LRRK2 kinase inhibitors.
- NEW MACROCYCLIC LRRK2 KINASE INHIBITORS - Compounds of Formula (I).
Conclusion
Maxime Laugeois is a promising inventor in the realm of precision medicine, and his ongoing research may lead to significant breakthroughs in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile